Skip to main content
Equibles

ENTERO · Entero Healthcare Solutions Limited · Documents

Use ENTERO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENTERO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,971.30 INR -3.85 (-0.19%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 5450 Avg daily vol (3M) 41.56K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 5, 2026
2026
Nov 5
Earnings call
Revenue rises 32.9%, management expects guidance beat

Entero Healthcare Solutions Limited reported Q2 revenue of INR2,087 crores, up 32.9%, and EBITDA growth of 78%; management expects to beat FY 2027 guidance of approximately 23% revenue growth, a 5% EBITDA margin and 50% EBITDA-to-operating-cash-flow conversion.

4 source passages
Entero Healthcare Solutions Limited Q2FY27 earnings call hosted by DAM Capital Advisors. Consolidated revenues grew by 32.9% to INR2,087 crores. Gross margin expanded 126 basis points year-on-year to 11.5%, and EBITDA margin expanded 135 basis points to 5.3%, and EBITDA grew by 78% year-on-year. We remain confident of sustaining the momentum in second half of the financial year and are in a comfortable position to deliver better than our stated FY 2027 guidance - which is consolidated revenue growth of approximately 23% (excluding any contribution from new acquisitions), alongside an EBITDA margin of 5% and EBITDA to operating cash flow conversion of 50%. Open the document at this passage
Showing 1–4 of 4 documents